Whalerock Point Partners, LLC Northwest Biotherapeutics Inc Transaction History

Whalerock Point Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$0.2 - $0.28 $12,000 - $16,800	-60,000 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$0.26 - $0.34 $2,340 - $3,060	9,000 Added 17.65%	60,000 $16,000
Q1 2019 May 13, 2019	BUY	$0.21 - $0.34 $2,310 - $3,740	11,000 Added 27.5%	51,000 $14,000
Q3 2018 Mar 04, 2019	BUY	$0.18 - $0.24 $1,800 - $2,400	10,000 Added 33.33%	40,000 $8,000
Q1 2018 Apr 05, 2018	BUY	$0.25 - $0.37 $2,500 - $3,700	10,000 Added 50.0%	30,000 $8,000
Q3 2017 Oct 31, 2017	BUY	$0.16 - $0.24 $3,200 - $4,800	20,000	20,000 $4,000

674K

Ticker NWBO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,037,230,016
Market Cap $290M
Description
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...

Get notified when there are updates to the investment portfolio of Whalerock Point Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Whalerock Point Partners, LLC with notifications on news.